Staphylococcus aureus and chronic airway disease

World Allergy Organization Journal

Volumn 3, Issue 8, 2010, Pages 223-228

  Derycke, Lara ^a   Pérez Novo, Claudina ^a   Van Crombruggen, Koen ^a   Corriveau, Marie Noëlle ^b   Bachert, Claus ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Chronic rhinosinusitis; Innate and adaptive immune system; Nasal polyps; Staphylococcus aureus; Superantigens

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CORTICOSTEROID; DOXYCYCLINE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN E; INTERLEUKIN 5; MACROLIDE; METHYLPREDNISOLONE; OMALIZUMAB; OVALBUMIN; PEPTIDOGLYCAN; PLACEBO; RESLIZUMAB; SODIUM CHLORIDE; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN;

ADAPTIVE IMMUNITY; ANTIBIOTIC THERAPY; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CHRONIC RHINOSINUSITIS; CLINICAL TRIAL; DENDRITIC CELL; DISEASE SEVERITY; DRUG EFFICACY; EOSINOPHILIA; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MEDIATOR; NONHUMAN; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; RHINOSINUSITIS; RISK FACTOR; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL; UPPER RESPIRATORY TRACT;

EID: 77958012436     PISSN: 19394551     EISSN: None     Source Type: Journal    
DOI: 10.1097/WOX.0b013e3181ecd8ae     Document Type: Review

References (53)

1. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinus-itis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngolo-gists. Rhinology. 2007;45:97-101.
2. Bachert C, Van Bruaene N, Toskala E, Zhang N, Olze H, et al. Important research questions in allergy and related diseases: 3-chronic rhinosinus-itis and nasal polyposis - a GALEN study. Allergy. 2009;64:520-533.
3. Van Zele T, Gevaert P, Watelet JB, Claeys G, Holtappels G, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol. 2004;114:981-983.
4. Sanderson AR, Leid JG, Hunsaker D. Bacterial biofilms on the sinus mucosa of human subjects with chronic rhinosinusitis. Laryngoscope. 2006;116:1121-1126.
5. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylo-coccus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505-520.
6. Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T, Kalbacher H, et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med. 2004;10: 243-245.
7. Ferrara A, Dos Santos C, Lupi A. Effect of some fractions of alveolar surfactant (phospholipids and SP-A) on the bactericidal activity of different antimicrobials against some respiratory pathogens. Clin Micro-biol Infect. 2001;7:114-119.
8. Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol. 2003; 133:299-306.
9. Li H, Llera A, Malchiodi EL, Mariuzza RA. The structural basis of T cell activation by superantigens. Annu Rev Immunol. 1999;17:435-466.
10. Van Zele T, Vaneechoutte M, Holtappels G, Gevaert P, van Cauwen-berge P, Bachert C. Detection of enterotoxin DNA in Staphylococcus aureus strains obtained from the middle meatus in controls and nasal polyp patients. Am J Rhinol. 2008;22:223-227.
11. Corriveau MN, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy. 2009;23: 461-465.
12. Muraille E, De Trez C, Pajak B, Brait M, Urbain J, Leo O. T cell-dependent maturation of dendritic cells in response to bacterial superantigens. J Immunol. 2002;168:4352-4360.
13. Mandron M, Ariès MF, Brehm RD, Tranter HS, Acharya KR, Charveron M, Davrinche C. Human dendritic cells conditioned with Staphylococ-cus aureus enterotoxin B promote TH2 cell polarization. J Allergy Clin Immunol. 2006;117:1141-1147.
14. Liu T, He SH, Zheng PY, Zhang TY, Wang BQ, Yang PC. Staphylo-coccal enterotoxin B increases TIM4 expression in human dendritic cells that drives naïve CD4 T cells to differentiate into Th2 cells. Mol Immunol. 2007;44:3580-3587.
15. Kirsche H, Niederführ A, Deutschle T, Fuchs C, Riechelmann H. Ratio of myeloid and plasmacytoid dendritic cells and TH2 skew in CRS with nasal polyps. Allergy. 2010;65:24-31.
16. Fournier B, Philpott DJ. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev. 2005;18:521-540.
17. Van Zele T, Coppieters F, Gevaert P, Holtappels G, Van Cauwenberge P, Bachert C. Local complement activation in nasal polyposis. Laryngoscope. 2009;119:1753-1758.
18. Dawicki W, Jawdat DW, Xu N, Marshall JS. Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol. 2010;184:2116-2123.
19. Barrett NA, Austen KF. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity. 2009;31:425-437.
20. Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F. Human mast cell activation by Staphylococcus aureus: Interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun. 2008;76:4489-4497.
21. Patou J, Gevaert P, Van Zele T, Holtappels G, van Cauwenberge P, Bachert C. Staphylococcus aureus enterotoxin B, protein A, and lipo-teichoic acid stimulations in nasal polyps. J Allergy Clin Immunol. 2008;121:110-115.
22. Claeys S, De Belder T, Holtappels G, Gevaert P, Verhasselt B, Van Cauwenberge P, Bachert C. Macrophage mannose receptor in chronic sinus disease. Allergy. 2004;59:606-612.
23. Watanabe I, Ichiki M, Shiratsuchi A, Nakanishi Y. TLR2-mediated survival of Staphylococcus aureus in macrophages: A novel bacterial strategy against host innate immunity. J Immunol. 2007;178:4917-4925.
24. Van Zele T, Claeys S, Gevaert P, Van Maele G, Holtappels G, Van Cauwenberge P, Bachert C. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280-1289.
25. Van Bruaene N, Pérez-Novo CA, Basinski TM, Van Zele T, Holtappels G, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008;121:1435-1441, 1441.e1-1441.e3.
26. Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol. 2008;122:961-968.
27. Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107:607-614.
28. Zhang N, Gevaert P, van Zele T, Perez-Novo C, Patou J, et al. An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology. 2005;43:162-168.
29. Van Zele T, Gevaert P, Holtappels G, van Cauwenberge P, Bachert C. Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy. 2007;37:1840-1847.
30. Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy. 2005;60:71-79.
31. Palmqvist N, Silverman GJ, Josefsson E, Tarkowski A. Bacterial cell wall expressed protein A triggers supraclonal B-cell responses upon in vivo infection with Staphylococcus aureus. Microbes Infect. 2005;7: 1501-1511.
32. Graille M, Stura EA, Corper AL, Sutton BJ, Taussig MJ, Charbonnier JB, Silverman GJ. Crystal structure of a Staphylococcus aureus protein A domain complexed with the fragment of a human IgM antibody: Structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci U S A. 2000;97:5399-5404.
33. Huvenne W, Callebaut I, Platinga M, Vanoirbeek JAJ, Krysko O, et al. Staphylococcus aureus enterotoxins B facilitates allergic sensiti-zation in experimental asthma. Clin Exp Allergy. 2010;40:1079-1090.
34. Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, et al. TGF-beta signaling and collagen deposition in chronic rhinosinus-itis. J Allergy Clin Immunol. 2009;124:253-259, 259.e1-259.e2.
35. Quinn GA, Cole AM. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology. 2007;122:80-89.
36. Pérez-Novo CA, Waeytens A, Claeys C, Cauwenberge PV, Bachert C. Staphylococcus aureus enterotoxin B regulates prostaglandin E2 synthesis, growth, and migration in nasal tissue fibroblasts. J Infect Dis. 2008;197:1036-1043.
37. Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: One airway disease. Immunol Allergy Clin North Am. 2004;24:19-43.
38. Bachert C, Patou J, Van Cauwenberge P. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol. 2006;6:29-36.
39. Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol. 2001;107: 73-80.
40. Hollams E, Hales B, Bachert C, Huvenne W, Parsons F, et al. Th2-associated immunity to bacteria in asthma in teenagers and susceptibility to asthma. Eur Respir J. 2010 doi:10.1183/09031936.00184109.
41. Fahrenholz JM. Natural history and clinical features of aspirin-exacerbated respiratory disease. Clin Rev Allergy Immunol. 2003;24: 113-124.
42. Pérez-Novo CA, Kowalski ML, Kuna P, Ptasinska A, Holtappels G, et al. Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: Studies on the relationship. Int Arch Allergy Immunol. 2004;133:255-260. (Pubitemid 38529218)
43. response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue. Allergy. 2010;65:304-310.
44. Harvey RJ, Wallwork BD, Lund VJ. Anti-inflammatory effects of macrolides: Applications in chronic rhinosinusitis. Immunol Allergy Clin North Am. 2009;29:689-703.
45. Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, et al. Oral steroids and doxycycline: Two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125:1069-1076.e4.
46. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284:1318-1322.
47. Huvenne W, van Bruaene N, Zhang N, van Zele T, Patou J, et al. Chronic rhinosinusitis with and without nasal polyps: What is the difference? Curr Allergy Asthma Rep. 2009;9:213-220.
48. García-Lara J, Foster SJ. Anti-Staphylococcus aureus immunotherapy: Current status and prospects. Curr Opin Pharmacol. 2009;9:552-557.
49. Hanlon GW. Bacteriophages: An appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents. 2007;30:118-128.
50. Sass P, Bierbaum G. Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol. 2007;73:347-352.
51. Son JS, Lee SJ, Jun SY, Yoon SJ, Kang SH, et al. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacte-riophage SAP-2 and a derived recombinant cell-wall-degrading enzyme. Appl Microbiol Biotechnol. 2010;86:1439-1449.
52. Gevaert P, Lang-Loidolt D, Lackner A, Stammberger H, Staudinger H, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol. 2006;118:1133-1141.
53. Verbruggen K, Van Cauwenberge P, Bachert C. Anti-IgE for the treatment of allergic rhinitis-and eventually nasal polyps? Int Arch Allergy Immunol. 2009;148:87-98.